Weekly Investment Analysts’ Ratings Changes for Fresenius Medical Care AG & Co. KGaA (FME)

Fresenius Medical Care AG & Co. KGaA (ETR: FME) recently received a number of ratings updates from brokerages and research firms:

  • 10/18/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €100.00 ($116.28) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 10/18/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €107.00 ($124.42) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock.
  • 10/17/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €78.00 ($90.70) price target on by analysts at Cfra. They now have a “neutral” rating on the stock.
  • 10/17/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €75.00 ($87.21) price target on by analysts at Credit Suisse Group AG. They now have a “neutral” rating on the stock.
  • 10/17/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €80.00 ($93.02) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 10/17/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €86.00 ($100.00) price target on by analysts at UBS Group AG. They now have a “neutral” rating on the stock.
  • 10/17/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €87.20 ($101.40) price target on by analysts at Barclays PLC. They now have a “neutral” rating on the stock.
  • 10/17/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €80.00 ($93.02) price target on by analysts at Commerzbank AG. They now have a “neutral” rating on the stock.
  • 10/17/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €85.00 ($98.84) price target on by analysts at Nord/LB. They now have a “buy” rating on the stock.
  • 10/17/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €97.90 ($113.84) price target on by analysts at JPMorgan Chase & Co.. They now have a “buy” rating on the stock.
  • 10/17/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €98.00 ($113.95) price target on by analysts at Goldman Sachs Group Inc. They now have a “buy” rating on the stock.
  • 10/17/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €107.00 ($124.42) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock.
  • 10/17/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €100.80 ($117.21) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 10/5/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €107.00 ($124.42) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock.
  • 10/1/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €82.00 ($95.35) price target on by analysts at Jefferies Financial Group Inc. They now have a “neutral” rating on the stock.
  • 10/1/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €107.00 ($124.42) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock.
  • 10/1/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €98.00 ($113.95) price target on by analysts at Goldman Sachs Group Inc. They now have a “buy” rating on the stock.
  • 10/1/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €97.90 ($113.84) price target on by analysts at JPMorgan Chase & Co.. They now have a “buy” rating on the stock.
  • 9/28/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €87.20 ($101.40) price target on by analysts at Barclays PLC. They now have a “neutral” rating on the stock.
  • 9/28/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €100.80 ($117.21) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 9/25/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €82.00 ($95.35) price target on by analysts at Jefferies Financial Group Inc. They now have a “neutral” rating on the stock.
  • 9/10/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €97.90 ($113.84) price target on by analysts at JPMorgan Chase & Co.. They now have a “buy” rating on the stock.
  • 8/31/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €86.00 ($100.00) price target on by analysts at UBS Group AG. They now have a “neutral” rating on the stock.
  • 8/31/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €87.20 ($101.40) price target on by analysts at Barclays PLC. They now have a “neutral” rating on the stock.
  • 8/30/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €98.00 ($113.95) price target on by analysts at Goldman Sachs Group Inc. They now have a “buy” rating on the stock.
  • 8/29/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €97.90 ($113.84) price target on by analysts at JPMorgan Chase & Co.. They now have a “buy” rating on the stock.
  • 8/28/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €107.00 ($124.42) price target on by analysts at HSBC Holdings plc. They now have a “buy” rating on the stock.
  • 8/24/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €98.00 ($113.95) price target on by analysts at Goldman Sachs Group Inc. They now have a “buy” rating on the stock.

ETR:FME opened at €70.80 ($82.33) on Friday. Fresenius Medical Care AG & Co. KGaA has a fifty-two week low of €75.53 ($87.83) and a fifty-two week high of €93.82 ($109.09).

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Featured Story: How are Outstanding Shares Different from Authorized Shares?

Receive News & Ratings for Fresenius Medical Care AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply